FDA 483 - CSL Behring GmbH - April 18, 2024
FDA 483 for CSL Behring GmbH on April 18, 2024. Product: biologics. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA 483 for CSL Behring GmbH on April 18, 2024. Product: biologics. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
CSL Behring GmbHInspection Date
April 18, 2024
Product Type
biologics
People
ID: 5e869e2f-39c4-427a-a730-ed3f66a5957b
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox